special considerations: when and what to start with viral hepatitis coinfections

17
IAS–USA Special Considerations: When and What to Start with Viral Hepatitis Coinfections Joseph J. Eron, Jr, MD Professor of Medicine University of North Carolina at Chapel Hill FINAL: 07-20-12

Upload: yaphet

Post on 23-Feb-2016

27 views

Category:

Documents


2 download

DESCRIPTION

Special Considerations: When and What to Start with Viral Hepatitis Coinfections. Joseph J. Eron , Jr , MD Professor of Medicine University of North Carolina at Chapel Hill. FINAL: 07-20-12 . Slide # 2. HCV and HIV – When and What to Start. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

IAS–USA

Special Considerations: When and What to Start with Viral

Hepatitis Coinfections

Joseph J. Eron, Jr, MDProfessor of Medicine

University of North Carolina at Chapel Hill

FINAL: 07-20-12

Page 2: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HCV and HIV – When and What to Start• RM is a 62 yo AA MSM who had a h/o

injection drug use in 1970’s.• He only accepted his sexual orientation in the

last 5 years after divorcing his wife. Since that time he has had multiple male sex partners and also consumed more alcohol than his typical 7-10 drinks per week. He has not injected drugs in 40 years.

• He presents to you after an evening of drinking when he vomited a modest about of blood

Slide #2

Page 3: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HCV and HIV – When and What to Start• He is found to have HCV genotype 1a and an HCV

VL of 2,700,000 c/mL, his HBV surface Ag is negative and surface Ab is positive

• He is HIV+ with CD4 of 850/µL and VL of 8,000 c/mL• On endoscopy he has small varices and no other

abnormalities• His AST is 90 and ALT 110, INR is 1.4 and albumin is

3.3. Plt count is 110. He has no ascites by exam and RUQ US and his liver is small and nodular appearing

• His HIV genotype shows K103N

Slide #3

Page 4: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HCV and HIV – When and What to Start

1. Obtain a liver biopsy2. Obtain a transient elastography3. Obtain an IL28b genotype4. None of the above – he needs to be

treated no matter what the results are5. Something else

Slide #4

What is your next step for his HCV after getting him to stop alcohol intake?

Page 5: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HCV and HIV – When and What to Start

1. Begin HCV therapy with interferon alfa and ribavirin lead-in and boceprevir

2. Begin HCV therapy with telaprevir, interferon alfa, and ribavirin

3. Begin HIV therapy first 4. Something else

Slide #5

You are confident that he needs HCV treatment but his hepatologist does a biopsy any way. Path is read as F3/4 but when pushed pathologist say more 4 than 3. He has decreased his drinking substantially and is on propranolol. What do you do now?

Page 6: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

Slide #6

HCV and HIV – When and What to Start

1. TDF/FTC2. ABC/3TC3. ZDV/3TC4. Something else

Slide #6

You decide that he should begin HIV therapy first and will start HCV therapy once HIV RNA is suppressed.Which NRTI combination will you choose? (HIV RNA 8,000 c/mL, CD4 850/µL and TDR with K103N)

Page 7: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

Slide #7

HCV and HIV – When and What to Start

1. FDC TDF/FTC/efavirenz2. FDC TDF/FTC/ rilpivirine3. FDC TDF/FTC/cobisistat/elvitegravir4. FDC TDF/FTC and raltegravir5. FDC TDF/FTC and atazanavir/r6. FDC TDF/FTC and darunavir/r7. Something else

Slide #7

You decide that he should begin HIV therapy first and will start HCV therapy once HIV RNA is suppressed.If you chose TDF/FTC which cART regimen would you start? (HIV RNA 8,000 c/mL, CD4 850/µL and TDR with K103N)

Page 8: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HCV and HIV – When and What to Start

1. Interferon alfa and ribavirin lead-in and boceprevir

2. Telaprevir, interferon alfa, and ribavirin3. Wait for the next approved drug (12 months

or so)4. Something else

Slide #8

You chose TDF/FTC and raltegravir (despite Dr. Eron’s concern re TDR).What HCV therapy will you start when he gets suppressed?

Page 9: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HCV and HIV – When and What to StartSlide #9

• On HIV therapy HIV RNA falls to < 50 c/mL with 8 weeks and his CD4 increases to 900/µL.

• However he presents with nausea and vomiting and his AST rises to 459 and ALT to 600, bilirubin rises slightly to 1.2 (was 0.8) and INR = 1.5.

Page 10: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

Slide #10

HCV and HIV – When and What to Start

1. Freak and call Jurgen Rockstroh

2. Continue treatment with weekly labs

3. Stop HIV therapy and wait for AST/AST to decline and then restart TDF/FTC ATV/r (or similar)

4. Stop HIV therapy and wait for AST/AST to decline and treat his HCV

5. Get a liver biopsy

6. Something else

Slide #10

What do you do?

Page 11: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

Slide #11

HIV and HBV

Page 12: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

Slide #12

HBV and HIV – What to Start• Robin M is Latina and 35 yo who was recently

diagnosed with HIV and HBV. She has had one male partner who is also HIV and HBV infected and unfortunately they do not always use condoms. He is currently suppressed on therapy but previously had failed a regimen of ZDV/3TC and EFV in 2005 or 2006 after several years of therapy.

• Robin M has been avoiding HIV and HBV testing for fear of a positive test. She has obesity (BMI 34), HTN and DM. Her last BP was 138/88 mmHg on lisinopril (ACE) and her last HgbA1C was 6.5% on metformin.

Slide #12

Page 13: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HBV and HIV – What to Start• Her CD4 cell counts is 358/µL with an HIV RNA of

320,000 c/mL• Her HBV viral load is 12,000,000 IU/mL and AST is

58 and ALT 70 IU/mL. INR, albumin and platelets are normal

• Her eGFR is 40 mL/min and she has 2+ protein and 2+ glc on UA with a urine prot/creatinine ratio of 800

Slide #13

Page 14: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HBV and HIV – What to Start

1. Yes2. No3. Not sure

Slide #14

A pre-therapy HIV genotype shows M41L and T215DWould you obtain an HBV resistance genotype?

Page 15: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HBV and HIV – What to Start• You decide to get a HBV resistance test

even though you are not 100% sure how it will effect your therapy choice.

• The results show the well-desribed rt M204V/I plus rt L180M mutations associated with lamivudine resistance.

Slide #15

Page 16: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

Slide #16

HBV and HIV – What to StartWhich antiviral combination will you begin?

1. FDC EFV/TDF/FTC2. TDF/FTC every other day with a recommended

third agent3. TDF/FTC every other day with a recommended

third agent plus entecavir4. ABC/3TC daily with a recommended third agent5. ABC/3TC daily with a recommended third agent

plus entecavir6. Something else

Slide #16

Page 17: Special Considerations: When and What to Start with Viral Hepatitis  Coinfections

HBV and HIV – What to Start

1. 0.5 mg daily2. 1.0 mg daily3. No tengo la menor idea!

Slide #17

If you chose to add entecavir what dose would you choose?